CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
High ImpactOriginal article

STAT+: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley

Positive
AI Analysis

Summary

Eli Lilly is acquiring psychedelics-focused biotech AtaiBeckley for $2.8 billion upfront to expand its neuroscience pipeline.

Importance:8/10
Sentiment:
0.60
M&Apsychedelicsneuroscienceacquisition
Related Companies

Read the original article

Published by STAT News on July 16, 2026 11:28 AM

Read Original